Background: Drug-related problems (DRPs) which arise from potentially inappropriate medications (PIMs) are a common problem in older people with multi-morbidity and polypharmacy. Aim: To develop an integrated PIM clinical decision support tool for identification of DRPs in geriatric multi-morbid polypharmacy patients, using the EU(7)-PIM and EURO-FORTA lists, with a focus on high-risk medications. Methods: The integrated PIM tool used the information on PIMs in both databases-the EU(7)-PIM and EURO-FORTA. PIMs were classified into four color groups based on risk profile: high-risk PIMs (should be avoided in older patients) as red, moderate-risk PIMs (require dose and/or treatment duration adjustment) as yellow, low-risk PIMs (low DRP risk) as green, and questionable PIMs (incomplete/missing information) as grey. Results: The summarized list of the high-risk (red and some grey) PIMs contained 81 active substances and medication classes. According to the ATC classification, most of the high-risk PIMs (n = 60, 74.1%) belong to the A, C, and N medication groups and 50.6% (n = 41) of the high-risk PIMs have currently marketing authorization in Estonia. The preliminary list of the moderate- and low-risk (yellow, green, and other grey) PIMs contained 240 active substances and medication classes, but sub-classification of this category into one or another group depends mainly on an individual patient´s clinical characteristics in a concrete analyzed study sample and needs further research. Conclusion: The integrated clinical decision support tool based on the EU(7)-PIM and EURO-FORTA criteria addresses the need for more efficient identification of DRPs. It can be applied to identify PIMs and geriatric prescribing problems in different health care settings, and also in a context of little clinical information available.

Department of Geriatrics and Gerontology 1st Faculty of Medicine Charles University Prague Czechia

Department of Social and Clinical Pharmacy Faculty of Pharmacy in Hradec Králové Charles University Prague Czechia

Faculty of Medicine Institute of Pharmacy University of Tartu Tartu Estonia

Touro University California College of Pharmacy Vallejo CA United States

Zobrazit více v PubMed

Alldred D. P., Kennedy M. C., Hughes C., Chen T. F., Miller P. (2016). Interventions to Optimise Prescribing for Older People in Care Homes. Cochrane Database Syst. Rev. 2, CD009095. 10.1002/14651858.cd009095.pub3 PubMed DOI PMC

Bala S., Chen T., Nishtala P. (2019). Reducing Potentially Inappropriate Medications in Older Adults: a Way Forward. Can. J. Aging/La Revue Canadienne Du Vieillissement 38. 10.1017/s0714980819000084 PubMed DOI

Botev N. (2012). Population Ageing in Central and Eastern Europe and its Demographic and Social Context. Eur. J. Ageing 9, 69. 10.1007/s10433-012-0217-9 PubMed DOI PMC

Cheen M. H. H., Tan Y. Z., Oh L. F., Wee H. L., Thumboo J. (2019). Prevalence of and Factors Associated with Primary Medication Non‐adherence in Chronic Disease: A Systematic Review and Meta‐analysis. Int. J. Clin. Pract. 73, e13350. 10.1111/ijcp.13350 PubMed DOI

Crealey G. E., Sturgess I. K., McElnay J. C., Hughes C. M. (2012). Pharmaceutical Care Programmes for the Elderly: Economic Issues. PharmacoEconomics 21, 455–465. 10.2165/00019053-200321070-00001 PubMed DOI

Crutzen S., Schuling J., Hugtenburg J. G., Verduijn M., Teichert M., Taxis K., et al. (2019). Development and Piloting of an Algorithm to Select Older Patients for Different Types of Medication Review. Front. Pharmacol. 10, 217. 10.3389/fphar.2019.00217 PubMed DOI PMC

Curtin D., Gallagher P. F., O’Mahony D. (2019). Explicit Criteria as Clinical Tools to Minimize Inappropriate Medication Use and its Consequences. Ther. Adv. Drug Saf. 13, 2042098619829431. 10.1177/2042098619829431 PubMed DOI PMC

E-Estonia: healthcare (2020). https://e-estonia.com/solutions/healthcare/e-health-record/(Accessed Nov 10, 2020).

Elseviers M. M., Vander Stichele R. R., Van Bortel L. (2014). Quality of Prescribing in Belgian Nursing Homes: an Electronic Assessment of the Medication Chart. Int. J. Qual. Health Care 26, 93. 10.1093/intqhc/mzt089 PubMed DOI

European Monitoring Centre for Drugs and Drug Addiction (2019). European Drug Report 2019: Trends and Evelopments. Luxembourg: Publications Office of the European Union; . https://www.emcdda.europa.eu/system/files/publications/11364/20191724_TDAT19001ENN_PDF.pdf (Accessed Apr, 2021).

Fialová D., Brkić J., Laffon B., Reissigová J., Grešáková S., Dogan S., et al. (2019). Applicability of EU(7)-PIM Criteria in Cross-National Studies in European Countries. Ther. Adv. Drug Saf. 24, 10:2042098619854014. 10.1177/2042098619854014 PubMed DOI PMC

Fialova D., Topinkova E., Gambassi G., Finne-Soveri H., Jonsson P. V., Carpenter I., et al. (2005). Potentially Inappropriate Medication Use Among Elderly home Care Patients in Europe. JAMA 291, 1348. 10.1001/jama.293.11.1348 PubMed DOI

Foubert K., Capiau A., Mehuys E., De Bolle L., Somers A., Petrovic M., et al. (2021). Ghent Older People's Prescriptions Community Pharmacy Screening (GheOP3S)-Tool Version 2: Update of a Tool to Detect Drug-Related Problems in Older People in Primary Care. Drugs Aging 38, 523–533. 10.1007/s40266-021-00862- PubMed DOI PMC

Gudi S. K., Kashyap A., Chhabra M., Rashid M., Tiwari K. K. (2019). Impact of Pharmacist-Led home Medicines Review Services on Drug-Related Problems Among the Elderly Population: a Systematic Review. Epidemiol. Health 41, e2019020. 10.4178/epih.e2019020 PubMed DOI PMC

Inxbase and Riskbase Databases. 2020. . https://ravimid.med24.ee/#search Accessed 12 Nov 2020.

Johansen J. S., Halvorsen K. H., Svendsen K., Havnes K., Carcia B. H. (2020). The Impact of Hospitalisation to Geriatric Wards on the Use of Medications and Potentially Inappropriate Medications - a Health Register Study. BMC Geriatr. 10.1186/s12877-020-01585-w 10.1186/s12877-020-01585-w PubMed DOI PMC

Lau E., Dolovich L. R. (2005). Drug-related Problems in Elderly General Practice Patients Receiving Pharmaceutical Care. IJPP 129, 319. 10.1211/ijpp.13.3.0002 DOI

O'Mahony D., O'Sullivan D., Byrne S., O'Connor M. N., Ryan C., Gallagher P. (2015). STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. PubMed PMC

Pazan F., Kather J., Wehling M. (2019). A Systematic Review and Novel Classification of Listing Tools to Improve Medication in Older People. Eur. J. Clin. Pharmacol. Eur. J. Clin. Pharmacol. 50, 108. 10.1007/s00228-019-02634-z PubMed DOI

Pazan F., Weiss C., Wehling M. (2018). The EURO-FORTA (Fit fOR the Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People. Drugs Aging 35, 61. 10.1007/s40266-017-0514-2 PubMed DOI

Rantsi M., Hyttinen V., Jyrkkä J., Vartiainen A. K., Kankaanpää E. (2021). Process Evaluation of Implementation Strategies to Reduce Potentially Inappropriate Medication Prescribing in Older Population: A Scoping Review. Res. Social Adm. Pharm. 18 (3), 2367–2391. 10.1016/j.sapharm.2021.04.012 PubMed DOI

Reeve E. (2020). Deprescribing Tools: a Review of the Types of Tools Available to Aid Deprescribing in Clinical Practice. J. Pharm. Pract. Res. 50, 98. 10.1002/jppr.1626 DOI

Reich O., Rosemann T., Rapold R., Blozik E., Senn O. (2014). Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization. PLoS One 19, e105425. 10.1371/journal.pone.0105425 PubMed DOI PMC

Renom-Guiteras A., Meyer G., Thürmann P. A. (2015). The EU(7)-PIM List: a List of Potentially Inappropriate Medications for Older People Consented by Experts from Seven European Countries. Eur. J. Clin. Pharmacol. 71, 861. 10.1007/s00228-015-1860-9 PubMed DOI PMC

Sepp K., Tuula A., Bobrova V., Volmer D. (2021). Primary Health Care Policy and Vision for Community Pharmacy and Pharmacists in Estonia. Pharm. Pract. (Granada) 19, 2404. (Granada) [Internet]. 10.18549/pharmpract.2021.2.2404 PubMed DOI PMC

Siebert S., Elkeles B., Hempel G., Kruse J., Smollich M. (2013). The PRISCUS List in Clinical Routine. Practicability and Comparison to International PIM Lists. Z. Gerontol. Geriatr. 46, 35. PubMed

Šola K. F., Mucalo I., Brajković A., Jukić I., Verbanac D., Vladimir Knežević S. (2020). Drug Therapy Problems Identified Among Older Adults Placed in a Nursing home: the Croatian Experience. J. Int. Med. Res. 48, 300060520928791. 10.1177/0300060520928791 PubMed DOI PMC

Sönnerstam E., Sjölander M., Gustafsson M. (2017). An Evaluation of the Prevalence of Potentially Inappropriate Medications in Older People with Cognitive Impairment Living in Northern Sweden Using the EU(7)-PIM List. PubMed PMC

State Agency of Medicines (2019). Overview of Estonian Medicinal Products Market. Available at: https://www.ravimiamet.ee/en/overview-estonian-medicinal-products-market (Accessed Dec 10, 2020).

State Agency of Medicines (2020). The Register of Medicinal Products. Available at: https://www.ravimiregister.ee/en/publichomepage.aspx (Accessed Nov 30, 2020).

Statistics Estonia: Statistical Database. 2021. . https://andmed.stat.ee/en/stat Accessed Apr 2021.

Thummar M. H., Patel T. K., Godbole V. Y., Saurabh M. K. (2019). Comparison of Beers Criteria and EU(7) Potentially Inappropriate Medications List for the Potentially Inappropriate Medications in Indian Elderly Inpatients. Int. J. Basic Clin. Pharmacol. 8, 1106. 10.18203/2319-2003.ijbcp20191609 DOI

Tommelein E., Petrovic M., Somers A., Mehuys E., Cammen T., Boussery K. (2016). Older Patients' Prescriptions Screening in the Community Pharmacy: Development of the Ghent Older People's Prescriptions Community Pharmacy Screening (GheOP³S) Tool. J. Public Health 38, e158. 10.1093/pubmed/fdv090 PubMed DOI

Tuula A., Volmer D., Jõhvik L., Rutkovska I., Trečiokienė I., Merks P., et al. (2021). Factors Facilitating and Hindering Development of a Medication Use Review Service in Eastern Europe and Iran-Cross-Sectional Exploratory Study. Healthcare 9, 1207. 10.3390/healthcare9091207 PubMed DOI PMC

Wamil N., Mattsson S., Gustafsson M. (2019). Assessment of Potentially Inappropriate Medications Using the EU (7)-PIM List and the Swedish Quality Indicators. Int. J. Clin. Pharm. 10.1007/s11096-019-00847-x PubMed DOI PMC

Wauters M., Elseviers M., Azermai M., Stichele R. V. (2016). Availability and Actual Use in the Belgian Market of Potentially Inappropriate Medications (PIMs) from the EU(7)-PIM List. Eur. J. Clin. Pharmacol. 72, 243. 10.1007/s00228-015-1947-3 PubMed DOI

Wehling M. (2016). How to Use the FORTA (“Fit fOR the Aged”) List to Improve Pharmacotherapy in the Elderly. Drug Res. 66, 57. 10.1055/s-0035-1549935 PubMed DOI